Schedules of Controlled Substance: Temporary Placement of 7-Hydroxymitragynine Above a Specified Threshold in Schedule I
The DEA is temporarily placing 7-hydroxymitragynine above a specified threshold in Schedule I, which may affect telemarketing and TCPA compliance for businesses marketing or selling products containing this substance. This change could trigger stricter consent requirements and potential liability under TCPA for calls or texts related to such products.
Aforeworn detected this change in the Telemarketing & TCPA Compliance space on July 5, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Contact centers, lead-gen/affiliates, SMS marketers, and debt/insurance dialers that market or sell products containing 7-hydroxymitragynine above the threshold. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Effective upon publication of the temporary order; immediate compliance recommended.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Telemarketing & TCPA Compliance continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
7-hydroxymitragynine above a specified threshold is now temporarily classified as a Schedule I controlled substance.
Who it affects
Contact centers, lead-gen/affiliates, SMS marketers, and debt/insurance dialers that market or sell products containing 7-hydroxymitragynine above the threshold.
What you must do
Review and update marketing lists and scripts to ensure no telemarketing or SMS campaigns promote or sell products containing this substance without proper legal compliance. Obtain prior express written consent for any communications related to Schedule I substances.
Deadline
Effective upon publication of the temporary order; immediate compliance recommended.
Never miss a change like this again
Aforeworn watches Telemarketing & TCPA Compliance around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Telemarketing & TCPA Compliance
- Elimination of the One-to-One Consent Rule Gives Companies Reprieve, Plus Other TCPA Updates - McGuireWoods
- FCC Extends Waiver That Would Require Callers To Apply a Revocation of Consent to All ‘Robocalls or Robotexts’ from the Caller - JD Supra
- WRITTEN CONSENT?: New Fifth Circuit Decision Says Congress Never Required It in the First Place! - TCPAWorld
- The Fifth Circuit Says You Can’t Write “Written” into the TCPA - The National Law Review
- Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; and Quality Reporting Programs; Including the Hospital Outpatient Quality Reporting Program and Ambulatory Surgical Center Quality Program; Request for Information on Strengthening the Standardization and Comparability of Hospital Price Transparency (HPT) Data; Prior Authorization; Accrediting Organization (AO) Deeming for Emergency Medical Treatment and Labor Act (EMTALA); and Notices of Closure of Teaching Hospitals and Opportunities To Apply for Available Slots